Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Saeid Heidari Keshel"'
Autor:
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi, Masoud Soleimani, Massoud Vosough, Seyedeh-Esmat Hosseini, Hamed Hossieni, Saeid Heidari Keshel, Zeinab Naderpour, Ensiyeh Hajizadeh-Saffar, Elham Shajareh, Hamidreza Jamaati, Mina Soufi-Zomorrod, Naghmeh Khavandgar, Hediyeh Alemi, Aliasghar Karimi, Neda Pak, Negin Hossieni Rouzbahani, Masoumeh Nouri, Majid Sorouri, Ladan Kashani, Hoda Madani, Nasser Aghdami, Mohammad Vasei, Hossein Baharvand
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2021)
Abstract Background Acute respiratory distress syndrome (ARDS) is a fatal complication of coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human mesenchymal stem cells (MSCs) as a potential treatment for ARDS. In this phase
Externí odkaz:
https://doaj.org/article/6c478e3e60944ae99b138d85d5c1ff70
Autor:
Esmaeil Biazar, Saeid Heidari Keshel, Vahid Niazi, Nader Vazifeh Shiran, Roxana Saljooghi, Mina Jarrahi, Ahmad Mehdipour Arbastan
Publikováno v:
RSC Advances. 13:6171-6180
Hemorrhage control is vital for clinical outcomes after surgical treatment and pre-hospital trauma injuries.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43629c4e318bfe4db6ca02689b6ade62
https://doi.org/10.1039/d2ra07795g
https://doi.org/10.1039/d2ra07795g
Autor:
Ladan Kashani, Mina Soufizomorrod, Rasoul Aliannejad, Ensiyeh Hajizadeh-Saffar, Seyed-Mohammad Reza Hashemian, Aliasghar Karimi, Hamidreza Jamaati, Hamed Hossieni, Nasser Aghdami, Negin Hossieni Rouzbahani, Hoda Madani, Massoud Vosough, Seyedeh-Esmat Hosseini, Hediyeh Alemi, Neda Pak, Mohammad Vasei, Masoud Soleimani, Hossein Baharvand, Morteza Zarrabi, Masoumeh Nouri, Zeinab Naderpour, Elham Shajareh, Majid Sorouri, Naghmeh Khavandgar, Saeid Heidari Keshel
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-12 (2021)
Background Acute respiratory distress syndrome (ARDS) is a fatal complication of coronavirus disease 2019 (COVID-19). There are a few reports of allogeneic human mesenchymal stem cells (MSCs) as a potential treatment for ARDS. In this phase 1 clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1f31a8f58f9b392239c47c81fbb7fd
https://doi.org/10.1186/s13287-021-02165-4
https://doi.org/10.1186/s13287-021-02165-4
Autor:
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Zarrabi, Morteza, Soleimani, Masoud, Vosough, Massoud, Seyedeh-Esmat Hosseini, Hossieni, Hamed, Saeid Heidari Keshel, Naderpour, Zeinab, Ensiyeh Hajizadeh-Saffar, Shajareh, Elham, Hamidreza Jamaati, Soufi-Zomorrod, Mina, Khavandgar, Naghmeh, Hediyeh Alemi, Aliasghar Karimi, Pak, Neda, Negin Hossieni Rouzbahani, Nouri, Masoumeh, Sorouri, Majid, Kashani, Ladan, Madani, Hoda, Aghdami, Nasser, Vasei, Mohammad, Baharvand, Hossein
Additional file 1: Figure S1. Flow cytometric characterization of UC-MSCs. The cells were negative for (A) CD31 (endothelial marker), (B) CD45, (C) CD34 (hematopoietic stem cell markers), (D) CD11b (leukocyte marker), and (E) HLD-R (MHC-II). They dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a96ce9b4a621324bec37f7ed98f435e
Autor:
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Zarrabi, Morteza, Soleimani, Masoud, Vosough, Massoud, Seyedeh-Esmat Hosseini, Hossieni, Hamed, Saeid Heidari Keshel, Naderpour, Zeinab, Ensiyeh Hajizadeh-Saffar, Shajareh, Elham, Hamidreza Jamaati, Soufi-Zomorrod, Mina, Khavandgar, Naghmeh, Hediyeh Alemi, Aliasghar Karimi, Pak, Neda, Negin Hossieni Rouzbahani, Nouri, Masoumeh, Sorouri, Majid, Kashani, Ladan, Madani, Hoda, Aghdami, Nasser, Vasei, Mohammad, Baharvand, Hossein
Additional file 2: Figure S2. Timeline for ICU admitted the patients treated with MSCs. (A) Survivors. (B) Non-survivors. Nine patients received three intravenous (IV) infusions. The course of cell therapy of patient number #8 was interrupted followi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3046ac37a22c9fbf07ffcf778d11cc90
Autor:
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Zarrabi, Morteza, Soleimani, Masoud, Vosough, Massoud, Seyedeh-Esmat Hosseini, Hossieni, Hamed, Saeid Heidari Keshel, Naderpour, Zeinab, Ensiyeh Hajizadeh-Saffar, Shajareh, Elham, Hamidreza Jamaati, Soufi-Zomorrod, Mina, Khavandgar, Naghmeh, Hediyeh Alemi, Aliasghar Karimi, Pak, Neda, Negin Hossieni Rouzbahani, Nouri, Masoumeh, Sorouri, Majid, Kashani, Ladan, Madani, Hoda, Aghdami, Nasser, Vasei, Mohammad, Baharvand, Hossein
Additional file 4: Table S2. Laboratory findings before the first and after the last cell infusions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a679bd8fefcb81b0a6952876376cfca
Autor:
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Zarrabi, Morteza, Soleimani, Masoud, Vosough, Massoud, Seyedeh-Esmat Hosseini, Hossieni, Hamed, Saeid Heidari Keshel, Naderpour, Zeinab, Ensiyeh Hajizadeh-Saffar, Shajareh, Elham, Hamidreza Jamaati, Soufi-Zomorrod, Mina, Khavandgar, Naghmeh, Hediyeh Alemi, Aliasghar Karimi, Pak, Neda, Negin Hossieni Rouzbahani, Nouri, Masoumeh, Sorouri, Majid, Kashani, Ladan, Madani, Hoda, Aghdami, Nasser, Vasei, Mohammad, Baharvand, Hossein
Additional file 3: Table S1. Clinical data before the first (day one) and last (day 5) cell infusions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084311df2fde91fa8608557b6d9e90a5